Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/14/2003US6632791 Thrombomodulin analogs for pharmaceutical use
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase
10/14/2003US6632671 Nanoparticle encapsulation system and method
10/14/2003US6632670 Recombinant adeno-associated virus (AAV) with reduced levels of helper virus; cells which have been transfected with plasmid comprising nucleotide sequences encoding replication (rep) and capsid (cap) proteins
10/14/2003US6632667 Using a antisense oligonucleotides targeted to a untranslated region or a stop codon region of a nucleic acid; use in treatment of Crohn's disease, diabetes, multiple sclerosis, rheumatoid arthritis, hepatitis, pancreatitis and asthma
10/14/2003US6632648 Methods of terminal sterilization of fibrinogen
10/14/2003US6632634 Decay accelerating factor (DAF) and nucleic acid encoding it
10/14/2003US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy
10/14/2003US6632627 DNA coding for the protein; useful for a prophylactic or therapeutic agent for hypoglycemia.
10/14/2003US6632626 Cancer; anticarcinogenic agents; use of purified enzyme in screening protocols for the identification of possible anti-cancer agents which inhibit the enzyme and thereby prevent expression of the oncogenic ras proteins such as p21ras
10/14/2003US6632618 Morphogenic protein-specific cell surface receptors and uses therefor
10/14/2003US6632617 Tumor-associated antigen
10/14/2003US6632616 A peptide or polypeptide containing tryptophan and a charged amino acid selected from lysine, arganine and histidine and the compound is conjugated to a detactable group, useful to detect an expanded polyglutamine doamine in a sample
10/14/2003US6632604 Nucleic acid sequences of CIITA genes which can be involved in controlling and regulating the expression of genes encoding MHC type II molecules, and their use, in particular as drugs
10/14/2003US6632446 Biocompatible substrates; free radical polymerization initiator; crosslinked networks of water soluble polymers; acrylated polyethylene glycol; microencapsulation
10/14/2003US6632441 Mutants of streptococcal toxin a and methods of use
10/14/2003US6632440 Chronic obstructive pulmonary disease (COPD), asthma; Aerosol administration a compound that inhibits exocytosis in mucus secreting cells produced by modifying a clostridial neurotoxin
10/14/2003US6632438 Vaccines
10/14/2003US6632437 Immunogenic polysaccharide-protein conjugates containing poly α(2→8), α(2→9) NeuNAc capsular polysaccharides
10/14/2003US6632434 Leptospiral major outer membrane protein, LipL 32
10/14/2003US6632433 Treating cholinergic controlled secretions including excess sweating, lacrimation and mucus secretion to reduce them; smooth muscle disorders; antispasmodic agents; analgesics; cardiovascular arterioles; gastrointestinal disorders
10/14/2003US6632432 Plasma from donors immunized with Staphylococcal epidermidis vaccine comprising antigens in TCA (trichloroacetic acid) extractions
10/14/2003US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification
10/14/2003US6632429 Methods for treating pervasive development disorders
10/14/2003US6632426 G-CSF analog compositions and methods
10/14/2003US6632424 Stimulate proliferation of hematopoietic stem or progenitor cells
10/14/2003US6632028 Apparatus and method for aligning an optical fiber with an optical device
10/14/2003CA2367107C Methods for limiting scar and adhesion formation
10/14/2003CA2288376C Syndecan interacting proteins and the use thereof
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/14/2003CA2223505C Anti-fungal and anti-bacterial histatin-based peptides
10/14/2003CA2165828C Peptidase resistant thrombin receptor peptide ligand
10/14/2003CA2109424C Anti-free-radical topical composition based on a superoxide-dismutase and a phosphonic derivative
10/14/2003CA2080018C Novel t-cell lymphoma cdna clones
10/14/2003CA2074820C Improved cyclodextrin based erythropoietin formulation
10/14/2003CA2040001C Hypoallergenic wheat preparation, process for producing the same, and processed food including the same
10/09/2003WO2003083485A2 Protein for use in hypoxia related conditions
10/09/2003WO2003083472A1 Method of judging risk of peiodontal disease
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083117A2 Vascularization controlling gene
10/09/2003WO2003083116A1 Emthod of screening transporter inhibitor
10/09/2003WO2003083114A1 Antiopoietin-related growth factor
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083110A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/09/2003WO2003083096A2 Cancer associated protein kinases and their uses
10/09/2003WO2003083085A2 Transporters and ion channels
10/09/2003WO2003083084A2 Protein modification and maintenance molecules
10/09/2003WO2003083083A2 Methods of using flt3-ligand in immunization protocols
10/09/2003WO2003083082A2 Enzymes
10/09/2003WO2003083080A2 Mixed- cell gene therapy
10/09/2003WO2003083079A2 Bone generation by gene therapy
10/09/2003WO2003083078A2 Novel human cell surface protein with immunoglobulin folds, bgs-19
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083046A2 Novel proteins and nucleic acids encoding same
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082926A2 Antimicrobial polymer conjugates
10/09/2003WO2003082924A1 Immunotherapeutic and immunoprophylactic reagents
10/09/2003WO2003082921A1 Lactoferrin
10/09/2003WO2003082920A1 Chemokines and uses thereof
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082918A1 Vegf peptides and their use
10/09/2003WO2003082915A2 Xcrf polynucleotides and polypeptides and uses thereof
10/09/2003WO2003082914A1 Prothrombin activating protein
10/09/2003WO2003082908A2 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein
10/09/2003WO2003082907A1 Ligands for g protein coupled receptor gpr7 and uses thereof
10/09/2003WO2003082906A2 Neurotrophic and neuroprotective peptides
10/09/2003WO2003082902A2 Novel corticotropin-releasing hormone analogs
10/09/2003WO2003082898A2 Novel analogues of glucose-dependent insulinotropic polypeptide
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082392A2 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003WO2003082370A2 Transcellular drug delivery system
10/09/2003WO2003082359A1 Tissue treatment
10/09/2003WO2003082349A1 Treatment methods for eotaxin mediated inflammatory conditions
10/09/2003WO2003082348A1 Nanogel networks including polyion polymer fragments and biological agent compositions thereof
10/09/2003WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
10/09/2003WO2003082344A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
10/09/2003WO2003082334A1 Drugs for increasing lacrimal fluid
10/09/2003WO2003082326A1 Use of aprotinin for treating wounds and inflammation
10/09/2003WO2003082325A1 Intraventricular hemorrhage thrombolysis
10/09/2003WO2003082324A1 Prevention and treatment of mycoplasma-associated diseases
10/09/2003WO2003082323A1 A composition and method for killing of tumours
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082321A1 Dental viscous pharmaceutical containing basic fibroblast growth factor
10/09/2003WO2003082319A1 Enhancement of endogenous gonadotropin production
10/09/2003WO2003082318A1 Use of angiotensin 1-7 for enhancing cardiac function
10/09/2003WO2003082317A1 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes
10/09/2003WO2003082315A1 Remedy for hypermyotonia
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082302A2 Bioadhesive directed somatic cell therapy
10/09/2003WO2003082269A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003WO2003082255A2 Use of mob-5 in pain
10/09/2003WO2003082248A2 Taste masked compositions of erythromycin a and derivatives thereof
10/09/2003WO2003082247A2 Drug microparticles
10/09/2003WO2003082217A2 Ctla4 compositions in the treatment of autism
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082212A2 Method for treating cancer in humans
1 ... 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 ... 3163